Diabetes and Alzheimer's Disease: Mechanisms and Nutritional Aspects
- PMID: 30406052
- PMCID: PMC6209735
- DOI: 10.7762/cnr.2018.7.4.229
Diabetes and Alzheimer's Disease: Mechanisms and Nutritional Aspects
Abstract
Blood glucose homeostasis is well maintained by coordinated control of various hormones including insulin and glucagon as well as cytokines under normal conditions. However, chronic exposure to diabetic environment with high fat/high sugar diets and physical/mental stress can cause hyperglycemia, one of main characteristics of insulin resistance, metabolic syndrome, and diabetes. Hyperglycemia impairs organogenesis and induces organ abnormalities such as cardiac defect in utero. It is a risk factor for the development of metabolic diseases in adults. Resulting glucotoxicity affects peripheral tissues and vessels, causing pathological complications including diabetic neuropathy, nephropathy, vessel damage, and cardiovascular diseases. Moreover, chronic exposure to hyperglycemia can deteriorate cognitive function and other aspects of mental health. Recent reports have demonstrated that hyperglycemia is closely related to the development of cognitive impairment and dementia, suggesting that there may be a cause-effect relationship between hyperglycemia and dementia. With increasing interests in aging-related diseases and mental health, diabetes-related cognitive impairment is attracting great attention. It has been speculated that glucotoxicity can result in structural damage and functional impairment of brain cells and nerves, hemorrhage of cerebral blood vessel, and increased accumulation of amyloid beta. These are potential mechanisms underlying diabetes-related dementia. Nutrients and natural food components have been investigated as preventive and/or intervention strategy. Among candidate components, resveratrol, curcumin, and their analogues might be beneficial for the prevention of diabetes-related cognitive impairment. The purposes of this review are to discuss recent experimental evidence regarding diabetes and cognitive impairment and to suggest potential nutritional intervention strategies for the prevention and/or treatment of diabetes-related dementia.
Keywords: Cognitive function; Dementia; Diabetes Mellitus; Hyperglycemia; Resveratrol.
Conflict of interest statement
Conflict of Interest: The authors declare that they have no competing interests.
Figures


Similar articles
-
[Alzheimer's disease and diabetes - the common pathogenesis].Neuropsychopharmacol Hung. 2016 Mar;18(1):5-19. Neuropsychopharmacol Hung. 2016. PMID: 27038867 Hungarian.
-
[Preventive strategy for cognitive decline in elderly with diabetes mellitus].Nihon Rinsho. 2014 Apr;72(4):692-6. Nihon Rinsho. 2014. PMID: 24796099 Japanese.
-
(Pre)diabetes, brain aging, and cognition.Biochim Biophys Acta. 2009 May;1792(5):432-43. doi: 10.1016/j.bbadis.2008.12.003. Epub 2008 Dec 16. Biochim Biophys Acta. 2009. PMID: 19135149 Review.
-
Type 2 diabetes mellitus and Alzheimer's disease.World J Diabetes. 2014 Dec 15;5(6):889-93. doi: 10.4239/wjd.v5.i6.889. World J Diabetes. 2014. PMID: 25512792 Free PMC article. Review.
-
R D Lawrence Lecture 2010. The brain as a target organ in Type 2 diabetes: exploring the links with cognitive impairment and dementia.Diabet Med. 2011 Feb;28(2):141-7. doi: 10.1111/j.1464-5491.2010.03199.x. Diabet Med. 2011. PMID: 21219420
Cited by
-
Role of sex and high-fat diet in metabolic and hypothalamic disturbances in the 3xTg-AD mouse model of Alzheimer's disease.J Neuroinflammation. 2020 Sep 29;17(1):285. doi: 10.1186/s12974-020-01956-5. J Neuroinflammation. 2020. PMID: 32993686 Free PMC article.
-
Signalling Pathways Implicated in Alzheimer's Disease Neurodegeneration in Individuals with and without Down Syndrome.Int J Mol Sci. 2020 Sep 20;21(18):6906. doi: 10.3390/ijms21186906. Int J Mol Sci. 2020. PMID: 32962300 Free PMC article. Review.
-
Intestinal Permeability and Oral Absorption of Selected Drugs Are Reduced in a Mouse Model of Familial Alzheimer's Disease.Mol Pharm. 2020 May 4;17(5):1527-1537. doi: 10.1021/acs.molpharmaceut.9b01227. Epub 2020 Apr 8. Mol Pharm. 2020. PMID: 32212738 Free PMC article.
-
Investigating the Effect and Mechanism of 3-Methyladenine Against Diabetic Encephalopathy by Network Pharmacology, Molecular Docking, and Experimental Validation.Pharmaceuticals (Basel). 2025 Apr 22;18(5):605. doi: 10.3390/ph18050605. Pharmaceuticals (Basel). 2025. PMID: 40430426 Free PMC article.
-
Palmitic Acid, but Not Lauric Acid, Induces Metabolic Inflammation, Mitochondrial Fragmentation, and a Drop in Mitochondrial Membrane Potential in Human Primary Myotubes.Front Nutr. 2021 May 31;8:663838. doi: 10.3389/fnut.2021.663838. eCollection 2021. Front Nutr. 2021. PMID: 34136519 Free PMC article.
References
-
- Fève B, Bastard JP. The role of interleukins in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol. 2009;5:305–311. - PubMed
-
- Akash MS, Rehman K, Liaqat A. Tumor necrosis factor-alpha: role in development of insulin resistance and pathogenesis of type 2 diabetes mellitus. J Cell Biochem. 2018;119:105–110. - PubMed
-
- Hemmingsen B, Gimenez-Perez G, Mauricio D, Roqué I Figuls M, Metzendorf MI, Richter B. Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database Syst Rev. 2017:CD003054. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources